Imaging Diagnostic Systems Attends China Med 2003
THURSDAY, NOVEMBER 13, 2003 9:54 AM
- PR Newswire
IMDS
0.97 +0.13
Enter Symbol:
Enter Keyword:
FORT LAUDERDALE, Fla., Nov 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- Imaging Diagnostic Systems, Inc. (IMDS) , an industry leader in the field of Medical Optical Imaging that developed a patented breast-imaging system that utilizes state-of-the-art laser technology and proprietary algorithms to create cross-sectional images and 3-D images of the breast for the detection of cancer, announced today the company is attending the 15th annual China Med 2003 from November 13-16, 2003 in Beijing, China.
Linda Grable, CEO of Imaging Diagnostic Systems, stated, "This will be our first year as an exhibitor at this conference along with our Chinese distributor. We are excited to have this opportunity to introduce the CTLM(R) system to the enormous Chinese healthcare market, to generate leads for future potential sales."
China Med (www.chinamed.net.cn) is becoming the largest medical instruments and equipment show in China. It has previously attracted 480 exhibitors and 43,000 attendees from all over the world. With the restructuring of the 175,000 medical institutions in China, the demand for medical appliances and equipment -- especially for high tech products, OEM equipment, physical therapy and household healthcare products -- is continually increasing. Exhibit categories at China Med 2003 will include medical electronics and ultrasound equipment, medical diagnostics and therapeutic instrumentation, rehabilitation and physical therapy products as well as dental equipment and ophthalmic products.
Imaging Diagnostic Systems has received CE Marking, UL listing, ISO 9001:2000 certification and FDA export certification for its CT Laser Breast imaging system. The CTLM(R) system is the first patented breast-imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography. The CTLM(R) system is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression.
THURSDAY, NOVEMBER 13, 2003 9:54 AM
- PR Newswire
IMDS
0.97 +0.13
Enter Symbol:
Enter Keyword:
FORT LAUDERDALE, Fla., Nov 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- Imaging Diagnostic Systems, Inc. (IMDS) , an industry leader in the field of Medical Optical Imaging that developed a patented breast-imaging system that utilizes state-of-the-art laser technology and proprietary algorithms to create cross-sectional images and 3-D images of the breast for the detection of cancer, announced today the company is attending the 15th annual China Med 2003 from November 13-16, 2003 in Beijing, China.
Linda Grable, CEO of Imaging Diagnostic Systems, stated, "This will be our first year as an exhibitor at this conference along with our Chinese distributor. We are excited to have this opportunity to introduce the CTLM(R) system to the enormous Chinese healthcare market, to generate leads for future potential sales."
China Med (www.chinamed.net.cn) is becoming the largest medical instruments and equipment show in China. It has previously attracted 480 exhibitors and 43,000 attendees from all over the world. With the restructuring of the 175,000 medical institutions in China, the demand for medical appliances and equipment -- especially for high tech products, OEM equipment, physical therapy and household healthcare products -- is continually increasing. Exhibit categories at China Med 2003 will include medical electronics and ultrasound equipment, medical diagnostics and therapeutic instrumentation, rehabilitation and physical therapy products as well as dental equipment and ophthalmic products.
Imaging Diagnostic Systems has received CE Marking, UL listing, ISO 9001:2000 certification and FDA export certification for its CT Laser Breast imaging system. The CTLM(R) system is the first patented breast-imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography. The CTLM(R) system is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression.
